Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Role of CEUS as a Secondary Diagnostic Modality
- Status
- UNKNOWN
- Phase
- NA
TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Optimization for Regorafenib in HCC
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Prediction of Liver-related Outcomes After HCV Cure
- Status
- UNKNOWN
- Phase
- N/A
Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC
- Status
- COMPLETED
- Phase
- N/A
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation
- Status
- RECRUITING
- Phase
- NA
A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function
- Status
- UNKNOWN
- Phase
- PHASE2
LiverMultiScan Analysis of MRI Scans in HCC
- Status
- COMPLETED
- Phase
- N/A
Hepatobiliary Tumors Tissue Samples Acquisition
- Status
- UNKNOWN
- Phase
- N/A
A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenvatinib in Combination With Camrelizumab as First-Line Therapy in Patients With Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.
- Status
- UNKNOWN
- Phase
- NA
The European NAFLD Registry
- Status
- RECRUITING
- Phase
- N/A
SBRT Versus Ablation for Perivascular Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors
- Status
- TERMINATED
- Phase
- N/A